Establishing Baseline Sysmex UF-5000 Flow Cytometer Results in Healthy Men

Launched by INDIANA UNIVERSITY · Apr 22, 2025

Keywords

ClinConnect Summary

This clinical trial is looking to improve the way we diagnose urethritis, which is an inflammation of the urethra that can occur even when a man has no symptoms. The study will test a new device called the Sysmex UF-5000 flow cytometer, which analyzes urine samples to count white blood cells. This can help doctors detect inflammation quickly and accurately, potentially leading to better management of sexually transmitted infections (STIs). The trial is focusing on healthy men aged 18 to 50 who do not have any symptoms like discharge or pain during urination.

Eligible participants will be asked to provide urine samples three times a week for two weeks, using both a standard urine cup and a special device called the Colli-Pee to see which method works better. By joining this study, participants can help researchers understand if this new testing method can improve early diagnosis and treatment of urethritis, making it easier for men to get the care they need.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Men aged 18 to 50.
• • No urethral symptoms (discharge, dysuria)
• Exclusion Criteria:
• • History of genital surgery or known urethral abnormalities
• • Testing positive for gonorrhea and chlamydia
• • Diagnosis of a sexually transmitted infection within the last year.
• • Not available to collect a urine specimen in the morning 3x/week for 2 weeks